Latest news
Cyclerion Therapeutics (CYCN) outlines terms, risks and disclosures for proposed Korsana merger - Stock TitanStock Titan · Fri, 07 Aug 2026 02:37:28 GMTCyclerion Therapeutics (NASDAQ: CYCN) outlines Korsana merger and going concern risk - Stock TitanStock Titan · Tue, 04 Aug 2026 20:16:39 GMTCyclerion (CYCN) and Korsana add leaders as reverse merger targets Q3 2026 close - Stock TitanStock Titan · Mon, 03 Aug 2026 21:14:31 GMTCyclerion Therapeutics Inc (CYCN) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTCYCN|Cyclerion Therapeutics Inc|Price:3.430|Chg%:-0.070 - TradingKeyTradingKey · Tue, 28 Jul 2026 07:00:00 GMTCyclerion Therapeutics Inc (CYCN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKeyTradingKey · Mon, 27 Jul 2026 15:05:47 GMTCyclerion Therapeutics Inc (CYCN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Mon, 27 Jul 2026 13:54:17 GMTCyclerion Therapeutics, Inc. SEC Filing (Jul 27, 2026) - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT